OpenAlex
PricingAboutJobs
Log inGet started
Work

A Novel Therapeutic Strategy to Rescue the Immune Effector Function of Proteolytically Inactivated Cancer Therapeutic Antibodies

HTML

Year: 2015
Type: article
Source: Molecular Cancer Therapeutics
DOI: 10.1158/1535-7163.mct-14-0715
Authors: Xuejun Fan, Randall J. Brezski, Hui Deng, Pooja M. Dhupkar, Yun Shi, Anneliese Gonzalez, Songlin Zhang, Michael Rycyzyn, William R. Strohl, Robert E. Jordan, Ningyan Zhang, Zhiqiang An
Institutions: Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, Janssen Research & Development (United States), The University of Texas Health Science Center at Houston
Language: English

Topic: Monoclonal and Polyclonal Antibodies Research
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Keywords: trastuzumab, ide, matrix metalloproteinases, antibody-dependent cellular cytotoxicity, Fc fragment, HER2, tumor immune evasion, Fc-engineered antibody, antibody resistance, tumor microenvironment, xenograft tumor model
SDG: Good health and well-being

Open Access status: closed

Funder: Janssen Research and Development
OpenAlex ID: W2087947321
FWCI: 1.344
Cites: 37
Cited by: 21
Related to: 8
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security